Taken together, our research indicated that ST3Gal IV was negatively associated with the pathological grade of cervical cancer tissues, and the overexpression of ST3Gal IV inhibited the growth and proliferation of cervical cancer cells in vivo and in vitro through Notch1/p21/CDKs signaling pathway. This evidence concerns the gene ST3GAL4 and cervical carcinoma.